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  College smoking correlates positively with depressive symptoms, and given the relation 
between smoking and mood regulation, cigarette smoking is a major health concern among 
depressed college smokers. This randomized clinical trial examined smoking reduction and 
cessation among college smokers with elevated depressive symptoms participating in a group-
based multi-component intervention including mood management, behavioral counseling, and 
motivational enhancement (CBT). Fifty-eight smokers (smoked 6 or more days in the past 30) 
were randomized to six sessions of the experimental intervention (n = 29) or a nutrition-focused 
attention-matched control group (CG; n = 29). Relative to CG participants, a significantly greater 
proportion of CBT participants reduced smoking intensity by 50 percent or more at end of 
treatment. In addition, confidence to reduce smoking increased significantly among CBT 
participants and decreased among CG participants from baseline to end of treatment. Overall, 
CBT participants maintained these changes at 3-month follow-up even though group differences 
were no longer statistically significant. Study findings demonstrate the feasibility of this 
intervention and support its utility for smoking reduction among depressed college students. 
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INTRODUCTION 
Cigarette Smoking among College Students 
Smoking is relatively common among college students. Whereas 9% of college students 
smoke daily, many more smoke occasionally (30-44%) (Johnston, O‟Malley, Bachman, & 
Schulenberg, 2007), and these occasional smokers have similar difficulties with quitting as adults 
(Okuyemi et al., 2002). In addition, although most people try their first cigarette before age 18 
(Centers for Disease Control and Prevention, 1997a), cross sectional surveys show that 11-28% 
of students begin smoking regularly while in college (Everett et al., 1999; Wechsler, Rigotti, 
Gledhill-Hoyt, & Lee, 1998). Furthermore, a recent longitudinal study found that 12% of non-
smokers became occasional smokers and 14% of occasional smokers progressed to daily 
smokers over the course of four collegiate years (Wetter et al., 2004). Taken together, research 
on college students suggests that smoking patterns evolve during the college years. Moreover, 
adult smoking patterns might become established in early adulthood, and therefore, college 
students are important targets for interventions aimed at decreasing use and preventing future 
smoking. 
Despite the high prevalence of tobacco smoking among college students and the 
feasibility of implementing programs into structured college or university settings (DeBernardo 
et al., 1999), few interventions have been designed and tested for this population. Existing 
cessation services often include „quit kits‟, self-help materials, and low-cost or free 
pharmacological aids, yet few of these programs have been evaluated (Halperin & Rigotti, 2003; 
Ramsay & Hoffmann, 2004). Moreover, most intervention research targeting college students 
lacks methodological rigor, such as random sampling, control groups, random assignment to 
groups, and biochemical validation of self-reported smoking (Murphy-Hoefer et al., 2005). A 
2 
 
recent review of interventions designed to reduce tobacco smoking among college students found 
seven published studies in the past 20 years. Of these seven studies, reviewers rated two 
„satisfactory‟ and one „unsatisfactory‟ based on appropriateness of study design, follow-up and 
completion rates, and data analysis. The remaining four studies were not rated due to small 
sample sizes (≤ 25 participants) or lack of a comparison group (Murphy-Hoefer et al., 2005). 
Despite methodological problems, the authors concluded that tobacco smoking interventions 
may reduce tobacco use among college students (Murphy-Hoefer et al., 2005). Indeed, Ramsay 
and Hoffmann (2004) found that a peer-led cessation and intervention program resulted in 88.2% 
quit rates among college smokers. Chan and Witherspoon (1988) evaluated the efficacy of a brief 
feedback counseling intervention and found it to be effective in increasing quit rates, reducing 
number of cigarettes smoked per day, and preventing initiation of tobacco use. These studies, 
though limited in number, suggest that smoking interventions may be successful in altering use 
among college students. Clearly, additional intervention research is needed for this population. 
Depression and Cigarette Smoking 
Research with adolescents and adults documents the association between depression and 
cigarette smoking. Among adolescents, depressive symptoms and depression diagnoses 
demonstrate cross-sectional associations with nicotine smoking and dependence (Breslau, 
Kilbey, & Andreski, 1991; Patton et al., 1996). Furthermore, research identifies depression as an 
important factor in the initiation and progression of adolescent smoking behavior (Brown, 
Lewinsohn, Seeley, & Wagner, 1996; Kandel & Davies, 1986; Patton et al., 1998; Windle & 
Windle, 2001), and other research suggests this relationship is bidirectional such that smoking 
may increase the risk for subsequent depressed mood (Steuber & Danner, 2006; Wu & Anthony, 
1999). Large population-based studies among adults observe higher rates of depression 
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diagnoses and symptoms in smokers than non-smokers (Anda et al., 1990; Glassman et al., 1990; 
Murphy et al., 2003). Other studies document a relationship between major depression (MDD) 
and nicotine dependence (Breslau et al., 1991; Breslau, Kilbey, & Andreski, 1993; Carton, 
Jouvent, & Widlocher, 1994), and level of nicotine consumption (Kendler et al., 1993). 
Furthermore, 61% of participants in a smoking cessation trial reported past MDD (Glassman et 
al., 1988), and other trials reveal that 34% to 48% of enrolled smokers present with clinically 
significant depressive symptomatology (Kinnunen, Doherty, Militello, & Garvey, 1996; Lerman 
et al., 1996; Lerman et al., 1998). 
Numerous recent studies demonstrate that the relationship between depression and 
smoking extends to young adults, including college students. For example, a national study of 
young adult smokers found depressive symptoms to be a unique predictor of lifetime and current 
nicotine dependence (Hu, Davies, & Kandel, 2006). In other studies of young adults, nicotine 
dependence was associated with higher rates of MDD (Breslau et al., 1991), and a history of 
MDD increased the risk for progression to daily smoking (Breslau, Peterson, Schultz, Chilcoat, 
& Andreski, 1998) and nicotine dependence (Breslau, Fenn, & Peterson, 1993). Research among 
college students reveals a relationship between a history of depression and smoking (Lenz, 2004; 
McChargue, Spring, Cook, & Neumann, 2004). Recent research has also shown that current 
cigarette and tobacco users report a significantly higher number of depressive symptoms 
(measured by the CES-D) than non-cigarette and non-tobacco users (Lee Ridner, Staten, & 
Danner, 2005; Vickers et al., 2003). Furthermore, a positive correlation exists between 
depressive symptoms and smoking level among college smokers (Lee Ridner et al., 2005; 
Schleicher, Harris, Catley, & Nazir, In Press). To this writer‟s knowledge, only one study failed 
to observe a relationship between depressive symptoms and nicotine dependence (Psujek, Martz, 
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Curtin, Michael, & Aeschleman, 2004). Accordingly, development of novel and efficacious 
smoking interventions for the subpopulation of depressed college student smokers is warranted. 
Depression and Smoking Cessation 
There is some evidence to suggest that depression impedes smoking cessation efforts. 
With regard to the relationship between past MDD and smoking cessation likelihood, findings 
are equivocal. Whereas some studies observed that past depression decreases likelihood of 
smoking cessation (Anda et al., 1990; Glassman et al., 1988; Murphy et al., 2003), others have 
not (Breslau et al., 1998; Ginsberg et al., 1997; John, Meyer, Rumpf, & Hapke, 2004a; Niaura et 
al., 1999). Results of a recent meta-analysis suggest that history of MDD is not an independent 
risk factor for cessation failure (Hitsman, Borrelli, McChargue, Spring, & Niaura, 2003); 
however, recurrent MDD might have a stronger relationship with quitting than a single past 
episode (Covey, Hughes, Glassman, Blazer, & George, 1994; Hitsman et al., 2003).  
Although a history of MDD is not consistently associated with cessation failure, currently 
depressed smokers (categorized based on symptoms of depression or diagnosis of depression) are 
less likely to stop smoking (Anda et al., 1990) and have higher relapse rates than nondepressed 
smokers (Hayford et al., 1999; Kinnunen et al., 1996; Niaura et al., 2001). Taken together, 
research suggests that current depressive symptoms may be a more important predictor of 
treatment outcome than history of MDD. This is especially true given that even low levels of 
baseline depressive symptoms predict poorer smoking abstinence rates (Niaura et al., 2001). 
Self-medication Model of Smoking and Depression 
A self-medication model has been used to account for the association between smoking 
and depression. According to this model, smokers “self-medicate” with nicotine to alter mood 
states by decreasing negative affect and increasing arousal (Carmody, 1989; Hall, Munoz, Reus, 
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& Sees, 1993; Hughes, 1988; Lerman et al., 1996; Pomerleau & Pomerleau, 1984). Research 
demonstrates that negative affect regulation expectancies, or beliefs about whether or not 
smoking will alleviate negative affect, might contribute to increased smoking. For example, 
among adolescents, affect regulation expectancy was related to experimental, regular, and 
established smoking (Mayhew, Flay, & Mott, 2000). In a sample of adults, depressed smokers 
reported smoking more in the presence of negative affect and had fewer coping resources than 
non-depressed smokers (Kinnunen et al., 1996). In other studies among adult smokers, negative 
affect regulation expectancies mediated the relationship between depressive symptoms and 
negative affect, on the one hand, and nicotine dependence on the other (Copeland, Brandon, & 
Quinn, 1995; Lerman et al., 1996). It is possible that depressed smokers have fewer coping 
resources than non-depressed smokers, and thus have a greater expectation that smoking will 
regulate mood. 
College students also report smoking to manage depression and stress (Patterson, 
Lerman, Kaufmann, Neuner, & Audrain-McGovern, 2004). For example, college student tobacco 
users with elevated depressive symptoms appear to be more likely to use tobacco for mood 
improvement than tobacco users with low depressive symptoms (Vickers et al., 2003). While one 
study found that negative affect regulation expectancies did not mediate the relationship between 
a history of depression and smoking status among college students (McChargue et al., 2004), a 
different study found that these expectancies did mediate the relationship between depressive 
symptoms and college student smoking status (Schleicher et al., In Press). Consequently, it 
appears that current depressive symptoms may be a more important predictor of negative affect 
regulation expectancies than history of depression. 
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Mood Management Interventions for Depressed Smokers 
Researchers have attempted to improve smoking cessation outcomes for depressed 
smokers with treatments targeting negative affect. Cognitive-behavioral mood management 
interventions (CBT) have become a recent focus of investigation as a smoking treatment adjunct 
for adult smokers with depression. Two studies by Hall and colleagues (1994; 1998) 
demonstrated that CBT was more effective than a behavioral smoking cessation treatment for 
smokers with a past history of MDD. However, when therapist contact time was controlled, there 
was no effect of CBT on smokers with a history of MDD (Hall et al., 1996). On the other hand, 
another study demonstrated that a 12-week CBT intervention was superior to a 12-week 
behavioral counseling intervention for adult smokers with histories of MDD and alcohol 
dependence (Patten, Martin, Myers, Calfas, & Williams, 1998). Results of two recent studies 
suggest that CBT may be superior to standard behavioral counseling for individuals with a 
history of multiple depressive episodes versus a single past episode of depression (Brown et al., 
2001; Haas, Munoz, Humfleet, Reus, & Hall, 2004). 
The findings in support of CBT for individuals with multiple past episodes of MDD 
parallels the research regarding historical depression and smoking abstinence and may explain 
the inconsistent results of the efficacy of CBT for historical depression. For example, smokers 
with recurrent MDD may have higher levels of mood disturbance than those with a single 
episode and thus may benefit from the addition of CBT to standard behavioral counseling (Haas 
et al., 2004). If this is the case, then CBT is likely to be valuable for smokers with clinically 
elevated depressive symptoms. Indeed, although most studies examining CBT for smoking 
exclude participants with current depression, additional research suggests that this type of 
intervention may be beneficial for smokers with current depressive symptoms. One study found 
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that smokers with high levels of baseline negative affect benefited more from CBT than smokers 
with low levels of negative affect (Brandon, Copeland, & Saper, 1995). In another study, 
participants high in baseline negative affect responded best to supportive counseling, while those 
low in negative affect responded best to skills training (Zelman, Brandon, Jorenby, & Baker, 
1992). Furthermore, in a recent study of adult smokers with a past history of alcohol dependence, 
post-treatment abstinence rates were higher for smokers with high baseline depressive symptoms 
who participated in CBT than for those in behavioral counseling (Patten, Drews, Myers, Martin, 
& Wolter, 2002). On the other hand, smokers with low baseline depressive symptoms responded 
better to behavioral counseling than to CBT. These results were significant after adjusting for 
history of MDD. The authors concluded that current depressive symptoms provide additional 
information in predicting short-term outcome beyond a diagnosis of major depression (Patten et 
al., 2002). Interestingly, three other studies did not find independent effects for baseline 
depressive symptoms or negative mood on abstinence rates following CBT (Brown et al., 2001; 
Brown et al., 2007; Haas et al., 2004). The conflicting findings among studies evaluating the 
effectiveness of CBT interventions for smokers experiencing depressive symptoms or negative 
affect may be related to symptom severity. For example, mood management interventions may 
be more effective for those with clinically elevated depressive symptoms than low or moderate 
levels of symptomatology (Brown et al., 2007). Given the strong positive correlation between 
high depressive symptoms and smoking, it is imperative for research studies to continue to 
develop and test interventions for this population. 
Summary 
Traditional CBT depression interventions treat current low mood and stress, yet few 
studies have targeted smokers with current clinical elevations in depression. As noted above, 
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depression and smoking are related, and current depressive symptomatology has the potential to 
impact smoking cessation efforts. Given the possible benefit of CBT for smoking, researchers 
should continue to develop and test interventions for depressed smokers. The college years 
represent a unique opportunity for psychotherapeutic interventions with potential to alter the 
course of lifelong smoking patterns. Moreover, college is a period of transition in which many 
experience negative mood (Eisenberg, Gollust, Golberstein, & Hefner, 2007). The self-
medication model suggests the likelihood that many college students will initiate, maintain, or 
increase smoking to cope with stress and negative affect. To date, however, no research has 
evaluated the effectiveness of mood management interventions for college student smokers 
experiencing high levels of depressive symptoms. 
To address this need, this study implemented a group-based CBT intervention targeting 
smoking reduction and cessation among college student smokers (smoking ≥ 6 days in the past 
30) with clinically elevated depressive symptomatology. For safety concerns, we excluded 
participants experiencing a current major depressive episode (MDE) (n = 4). The multi-
component CBT intervention combined mood management, behavioral counseling and 
motivational enhancement. We targeted occasional and daily smokers with varying interest in 
quitting because we wanted to derive a sample representative of the smoking college student 
population and because recent research suggests that the prevalence of occasional smoking is 
increasing (Tong, Ong, Vittinghoff, & Perez-Stable, 2006). Our intervention included a 
motivational enhancement component because we did not recruit students seeking treatment for 
smoking and, therefore, anticipated variability in their motivation to change their smoking 
behavior. Finally, in addition to smoking cessation, we targeted smoking reduction because of 
recent positive findings regarding reduction interventions for smokers not motivated to quit 
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(Hughes & Carpenter, 2005) and the apparent finding that these reductions might facilitate future 
cessation efforts (Carpenter, Hughes, Solomon, & Callas, 2004; Hughes & Carpenter, 2006). 
HYPOTHESES 
Primary Hypotheses 
Hypothesis 1 
Relative to participants in a nutrition-focused attention-matched control group (CG), 
participants receiving a multi-component experimental intervention (CBT) for smoking will have 
significantly higher 30-day abstinence (defined as no cigarettes in the past 30 days) at end of 
treatment (session 6; 8 weeks from baseline). 
Hypothesis 2 
Relative to CG participants, a significantly greater proportion of participants receiving 
CBT will achieve 50% or greater reduction in number of cigarettes smoked per month at end of 
treatment (session 6; 8 weeks from baseline). 
Secondary Hypotheses 
Hypothesis 3 
Relative to CG participants, participants receiving CBT will have significantly higher 30-
day abstinence (defined as no cigarettes in the past 30 days) at 3-month follow-up (12 weeks 
from baseline). 
Hypothesis 4 
Relative to CG participants, a significantly greater proportion of participants receiving 
CBT will achieve 50% or greater reduction in the number of cigarettes smoked per month at 3-
month follow-up (12 weeks from baseline). 
Exploratory Hypotheses 
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Hypothesis 5 
CBT for college student smokers with elevated depressive symptoms will be feasible, as 
evidenced by our ability to recruit and retain participants, treatment attendance, and participants‟ 
reports of treatment satisfaction. 
Hypothesis 6 
Comparing baseline to end of treatment and 3-month smoking levels, participants 
receiving CBT will have a significantly greater reduction in overall number of cigarettes smoked 
per month than participants in CG. 
Hypothesis 7 
Relative to CG participants, CBT participants will report significantly higher motivation 
and confidence to quit and reduce smoking at end of treatment and 3-month follow-up. 
Hypothesis 8 
Relative to CG participants, CBT participants will report significantly less severe 
depressive symptoms, negative affect, and negative affect regulation expectancies, and will 
report significantly higher positive affect and increased use of cognitive reappraisal strategies at 
end of treatment and 3-month follow-up. 
Hypothesis 9 
The relationship between baseline depressive symptoms and treatment attendance will be 
explored. 
METHODS 
Participants and Procedure 
As presented in the sampling diagram (Figure 1), 1,380 participants aged 18 years or 
older completed screening measures over the course of three academic semesters (2007-2008). 
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Participants completed measures during “Testing Day,” an event sanctioned by The University 
of Montana Psychology Department in which students enrolled in introductory psychology 
courses earn required research participation credit. Study personnel contacted participants via 
telephone who agreed to follow-up contact and met the following screening criteria: smoking ≥ 6 
days in the past 30, clinically significant depressive symptomatology (Center for 
Epidemiological Studies-Depression Scale (CES-D) sum ≥ 16 (Radloff, 1977)), and a degree of 
motivation to quit smoking (Contemplation Ladder rating ≥ 3, indicating some awareness of 
problems associated with smoking (Abrams et al., 2003; Biener & Abrams, 1991)). During a 
follow-up phone call, study personnel described the study, assessed exclusion criteria, and 
enrolled interested and consenting participants. Participants were excluded if they reported recent 
(past 30 days) participation in a structured smoking cessation program (n = 0), and for safety 
reasons if they reported current suicidal intent or plans (n = 0) or current MDE (n = 4, indexed 
using a diagnostic algorithm from the Patient Health Questionnare-9 (Kroenke, Spitzer, & 
Williams, 2001)). Table 1 summarizes inclusion and exclusion criteria. 
As shown in Figure 1, 58 undergraduate smokers with clinically elevated depressive 
symptomatology were randomized to participate in the CBT and CG groups. The 58 eligible 
participants were individually randomized to groups using a random number table and blocked 
random assignment. We blocked according to CDC-defined (Center for Disease Control and 
Prevention, 1994) smoking level (occasional smoking ≤ 19 days in the past 30 vs. frequent 
smoking ≥ 20 days in the past 30) and motivation to quit (Contemplation Ladder score ≤ 5 vs. ≥ 
6) so that groups were matched on these characteristics at baseline. Major assessment intervals 
occurred at screening, baseline (session 1: week 0), end of treatment (session 6: week 8), and 3-
month follow-up (12 weeks from baseline). The first five group sessions occurred weekly, and 
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the last group session took place 30 days after session 5 in order to assess 30-day smoking 
outcomes at end of treatment. The following incentives were provided: 1) partial course credit; 
2) non-monetary incentives (e.g., campus coupons and pizza at group sessions); 3) $50 for 
completing study measures. In addition, for each attended group session, participants entered 
their names in a drawing to win an iPod at the final group session. The Institutional Review 
Board at The University of Montana (UM) approved all study procedures; participants provided 
informed consent at screening and baseline. Table 2 summarizes the study overview and 
disbursement of incentives. 
Interventions 
Treatment Condition 
The treatment condition was an adaptation of a 12-week group-based combined 
behavioral counseling plus cognitive-behavioral mood management intervention (CBT). The 
original intervention significantly enhanced smoking treatment outcomes among abstinent 
alcoholics with a history of major depression in a previous study (Patten et al., 1998). This 
intervention was also found to be more effective than standard behavioral counseling for 
smokers experiencing high levels of current depressive symptomatology (Patten et al., 2002). We 
modified the 12-week intervention by reducing the number of sessions to 6 and keeping the 
session length at two hours for a couple of reasons. First, college students appear to value time-
limited interventions (Black & Babrow, 1991), and Dr. David Brown, a psychologist and group 
psychotherapist at the UM student counseling center, advised against conducting more than 6 
sessions due to participant attrition. Second, given that our primary outcome was 30-day 
smoking rate at end of treatment, we required 30 days between the final two sessions. This 
requirement made 6 sessions a more feasible option. We maintained the group-based approach 
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for the purpose of replication and time and cost considerations. Although the sessions were 
group-based, group discussion and problem solving allowed for some personalized instruction. 
In addition to the manual cited above, material from a clinical handbook on tobacco dependence 
treatment outlining an 8-week intensive mood management intervention was incorporated 
(Abrams et al., 2003). Participants were taught that smoking is a learned behavior, a physical 
addiction, and that smoking is related to mood. The CBT component outlined associations 
among triggers, thoughts, feelings, and behavior. Participants recorded their thoughts, and 
identified and challenged thought distortions related to negative mood and/or smoking. We also 
taught additional ways of managing mood, such as increasing pleasant smoke-free activities and 
relaxation. The behavioral counseling component included skills training such as self-monitoring 
of smoking and triggers, self-management strategies, making a quit or change plan, and relapse 
prevention. Finally, the smoking intervention included motivational approaches (Miller & 
Rollnick, 2002) such as expressing understanding, rolling with resistance, developing 
discrepancy (e.g., values clarification and pros and cons), and increasing self-efficacy. For 
example, participants ranked their motivation and confidence to quit on a scale from 1 (no 
motivation/confidence) to 10 (high motivation/confidence), and group leaders facilitated a 
dialogue about their locations on the scale. The group also created a pros and cons list of 
smoking and of quitting and/or reducing smoking. As outlined in Table 3, participants were 
given the opportunity to make a quit or change plan at session 4 and were given instructions on 
obtaining low-cost pharmacotherapy to support cessation efforts. Treatment groups were 
conducted by two graduate students in clinical psychology, including this writer, and they 
received weekly supervision from David Brown, Ph.D., a clinical psychologist at The University 
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of Montana‟s Counseling and Psychological Services (CAPS). In addition, Drs. Harris and 
Campbell provided consultation as needed. 
Control Condition 
The active control condition was a 6-session group designed to increase the consumption 
of fruit and vegetables to equate clinical contact time across experimental and control conditions. 
Neither smoking nor smoking cessation was discussed in the nutrition groups. Control groups 
were conducted by two graduate students in psychology or public health, and Drs. Harris and 
Campbell provided weekly supervision. 
Table 3 outlines the topics covered in the treatment and control conditions. Treatment 
groups took place at CAPS and control groups took place either at CAPS or the psychology 
building on campus. For the first two cohorts, all group leaders and supervisors attended a two-
hour peer-led motivational interviewing training. For the third cohort, all group leaders attended 
a two-day motivational interviewing workshop. Group leaders met at least once before groups 
began to review curricula. Weekly supervision included a review of plans for upcoming sessions. 
Measures 
Screening Measures 
Demographics. At screening, socio-demographic information (gender, age, and year in 
school) was assessed via self-report. 
Depressive Symptoms. The 20-item CES-D (Radloff, 1977) assessed depressive 
symptoms. Scores range from 0 to 60, with higher scores reflecting a greater number of 
depressive symptoms. The CES-D correlates highly with other self-report measures of 
depression and evidences good internal consistency (α = .85-.90) and test-retest reliability (r = 
.57 for 2-8 weeks) (Radloff, 1977). We used the standard cutoff score (Sum ≥ 16) to define 
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clinically significant depression. For missing items on the CES-D, we used item-mean 
imputation for participants with four or fewer items missing (n = 54 one item missing, n = 6 two 
items missing) (Bono, Ried, Kimberlin, & Vogel, 2007). The CES-D evidenced good internal 
consistency in the present sample (α = .89). 
Smoking Status. The Center for Disease Control and Prevention open-ended question, 
“During the past 30 days, on how many days did you smoke cigarettes?” assessed smoking status 
(1997b). Those who reported smoking on 6 or more days were considered eligible. 
Motivation to Quit. The Contemplation Ladder assessed motivation to quit smoking 
(Abrams et al., 2003; Biener & Abrams, 1991). This measure consists of an 11-point Likert scale 
measuring readiness to quit smoking, with a higher score representing greater motivation to 
change smoking behavior (e.g., “I have decided to quit smoking”) and a lower score representing 
less motivation to change (e.g., “I do not have a problem with smoking, and I do not intend to cut 
down or quit now”). Participants select the response that best describes their thoughts about their 
current smoking. The validity of the Contemplation Ladder has been demonstrated by comparing 
it to reported intention to quit and number of previous quit attempts, and by its ability to predict 
participation in treatment programs (Biener & Abrams, 1991). Participants scoring three or 
higher on this measure were considered eligible. 
Major Depressive Disorder. The 9-item Patient Health Questionnaire (PHQ-9) assessed 
for current MDE (Kroenke et al., 2001). Items assess the frequency with which the respondent 
experiences the 9 DSM-IV criteria for MDE; items are scored from 0 (“not at all”) to 3 (“nearly 
every day”). Total scores range from 0-27. We used a scoring algorithm such that individuals 
were excluded on the basis of MDE if: (1) they endorsed experiencing 5 of the 9 symptoms for at 
least “more than half the days” in the past 2 weeks (i.e., score at least “2” on 5/9 questions), (2) 
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one of the symptoms was depressed mood or anhedonia, and (3) they endorsed an additional item 
that assesses whether any of the measure‟s nine symptoms causes clinically significant 
impairment (Kroenke et al., 2001). Research suggests that a PHQ-9 score of 10 or more is a 
reliable and valid indicator of MDE (Adewuya, Ola, & Afolabi, 2006; Kroenke et al., 2001). The 
PHQ-9 has demonstrated good construct, concurrent, and criterion validity, and has been shown 
to have good internal consistency and test-retest reliability (Adewuya et al., 2006; Kroenke et al., 
2001). In addition, a recent study demonstrated that use of the PHQ-9 as a telephone screening 
assessment is concordant with self-administration and preserves the internal consistency of the 
items (Pinto-Meza, Serrano-Blanco, Penarrubia, Blanco, & Haro, 2005). The scale evidenced 
acceptable internal consistency in this sample (α = .71). 
Baseline, End of Treatment, and Follow-up Measures 
Demographics. At baseline only, ethnicity and previous and current counseling 
experience were assessed via self-report (e.g. “Have you ever received psychological counseling 
in the past?” and “Are you currently receiving psychological counseling?”). 
Smoking Status. Baseline and outcome smoking status were assessed by two forms of 
self-report. First, participants answered a single Center for Disease Control and Prevention 
(1997b) question (“During the past 30 days, on how many days did you smoke cigarettes?”). 
Data from this question were used for descriptive purposes only. Second, timeline follow-back 
(TLFB) procedures (Harris et al., In Press; Sobell & Sobell, 1996) assessed number of cigarettes 
smoked in the past 30 days. Trained independent evaluators instructed participants to use a 
calendar and memory aids (e.g., key dates like birthdays, exams, holidays) to provide 
retrospective estimates of the number of cigarettes smoked each day. To reduce intentional 
inaccuracy of these data we obtained saliva samples at end of treatment, informing participants 
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that samples would be tested for nicotine (Murray & Perry, 1987). All smoking outcomes were 
derived from TLFB data. For missing TLFB data, we inserted data based on smoking patterns 
from weekday and weekend use reported in the current month. Five participants had one item 
missing and two participants had two items missing. 
Motivation and Confidence. Four separate questions were modified from Miller and 
Rollnick (1991) to assess motivation and confidence to quit and reduce smoking at baseline and 
end of treatment. Participants indicated their levels of motivation and confidence to quit and 
reduce smoking on scales ranging from 0 (not at all motivated/confident) to 10 (Very 
motivated/confident). 
Depressive Symptoms. The 21-item Beck Depression Inventory-II (BDI-II, Beck, Steer, 
& Brown, 1996) assessed depressive symptoms. Scores range from 0 to 63, with higher scores 
reflecting more depressive symptomatology. The BDI-II demonstrates good internal consistency 
reliability (α = .93) and construct validity (Beck et al., 1996). At baseline the BDI-II evidenced 
good internal consistency in this sample (α = .90). For missing BDI-II data (n  =  4 one item 
missing) we replaced missing items with the mean values of the valid data by participant (Bono 
et al., 2007). Group leaders monitored suicidal ideation by assessing BDI-II item #9 (Suicidal 
Thoughts or Wishes). For any response other than „0‟ group leaders conducted a targeted suicide 
assessment. Participants reporting suicidal ideation or other concerning psychiatric symptoms 
were referred for treatment at CAPS. 
Negative and Positive Affect. The 20-item Positive Affect Negative Affect Schedule 
(PANAS) (Watson, Clark, & Tellegen, 1988) assessed positive and negative affect. The PANAS 
consists of two 10-item scales (Positive Affect, PA and Negative Affect, NA). The two scales 
have high internal consistency reliabilities (α = .84 to .90) and low intercorrelations (rs = -.12 to 
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-.23). At baseline, the NA scale evidenced acceptable internal consistency in this sample (α = 
.73), and the PA scale evidenced good internal consistency (α = .88). 
Smoking Expectancies. The 4-item Negative Affect Reduction (NAR) subscale of the 
Brief Smoking Consequences Questionnaire (SCQ) for college students (Schleicher, Harris, 
Catley, Harrar, & Golbeck, 2008) measured participants‟ expectancies that smoking would assist 
with negative affect regulation. Participants indicated the likelihood of smoking consequences on 
a Likert-type scale ranging from 0-10 (0=Not at all likely, 10=Extremely likely); higher scores 
reflected greater outcome expectancies (e.g., “Smoking calms me down when I feel nervous,” “If 
I am feeling irritable, a smoke will help me relax.”). The NAR subscale evidenced good internal 
consistency reliability in another college sample (α = .92) (Schleicher et al., 2008) and in this 
study at baseline (α = .85). 
Cognitive Reappraisal. The 6-item Reappraisal subscale of the Emotion Regulation 
Questionnaire (ERQ) assessed cognitive reappraisal (Gross & John, 2003). The Reappraisal 
subscale measures the extent to which participants use cognitive strategies to alter their emotions 
(e.g., “When I want to feel less negative emotion (such as sadness or anger), I change what I‟m 
thinking about”). Items are rated on a scale from 1 (strongly disagree) to 7 (strongly agree), with 
higher scores representing higher use of reappraisal as an emotion regulation strategy. In a 
college sample, the Reappraisal subscale demonstrated good internal consistency reliability 
(mean α = .79 across 4 samples) and convergent and discriminant validity (Gross & John, 2003). 
At baseline, the Reappraisal subscale evidenced good internal consistency in this sample (α = 
.85). 
 Pharmacotherapy Use. Pharmacotherapy use (i.e., any prescription drug) was assessed via 
self-report and included drug names, dosage, and dates of use. For descriptive purposes, drugs 
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were coded as present (1) or absent (2) for four drug categories of interest (anti-depressant, 
stimulant, mood stabilizer/anti-psychotic, and benzodiazepine). In addition, presence (1) or 
absence (2) of any psychotropic medication was coded. 
Additional Measures 
 Treatment Attendance. Participants signed in at each weekly session (baseline included) 
and were coded as 0 (absent) or 1 (present/made up session). Attendance scores were summed 
with scores ranging from 0 (no sessions attended) to 6 (all sessions attended). This sum provided 
an index of treatment adherence. 
 Treatment Satisfaction. Slightly modified versions of the 8-item Client Satisfaction 
Questionnaire (CSQ-8) (Attkisson & Zwick, 1982) assessed participants‟ satisfaction with both 
intervention conditions at end of treatment. Two forms were created specific to each 
intervention; questions addressed the helpfulness of the intervention (e.g., “How would you rate 
the helpfulness of this group for quitting smoking (CBT)/increasing fruit and vegetable 
consumption (CG)?”) and the likelihood of recommending the intervention to a friend (e.g., “If a 
friend were thinking about quitting or reducing his/her smoking (CBT)/increasing his/her fruit 
and vegetable consumption (CG), would you recommend our program to him/her?”). Items are 
scored on a 4-point Likert scale with “1” indicating the lowest degree of satisfaction and “4” the 
highest. Scores range from 8-32, with higher scores indicating higher satisfaction. 
 Therapist Adherence. To assess therapist adherence to the treatment manuals, group case 
notes for all cohorts and group sessions were read by two blind raters. Global topics were 
provided to the raters (e.g, CBT, behavioral counseling for smoking cessation, motivational 
enhancement, and fruit and vegetable education), and each rater indicated which topics were 
covered per session. Inter-rater agreement was high for CBT (κ = .88), behavioral counseling (κ 
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= .94), and fruit and vegetable education (κ = .94), and moderate for motivational enhancement 
(κ = .53). We chose to examine topics across sessions rather than per session for each cohort 
because dynamic improvements were made to the interventions (e.g., which topics were covered 
per session) for each cohort. The percent of sessions (averaged across raters) each topic was 
covered per cohort by intervention group is reported in table 4. 
Power Analysis 
An a priori power analysis indicated sufficient power (0.80) for n = 50 participants to 
detect a difference in abstinence rates at end of treatment between treatment and control groups. 
The abstinence rates for the control group (4% & 6%) were based on estimates of spontaneous 
and minimal intervention quit rates in the general population (Centers for Disease Control and 
Prevention, 1993; Curry, McBride, Grothaus, Louie, & Wagner, 1995; Glynn, Boyd, & Gruman, 
1990). Abstinence rates for the treatment group (38% to 69%) were based on previous studies of 
CBT for smoking cessation among adult smokers with and without a history of depression 
(Brown et al., 2001; Hall et al., 1996; Patten et al., 1998).  
Data Analyses 
We conducted analyses using two-tailed tests with p < .05 level of significance. 
Descriptive statistics summarized sample characteristics at screening and baseline. Group 
differences were assessed using independent t-tests for continuous variables and Pearson‟s Chi-
square test for categorical variables (Fischer‟s Exact when noted). We identified potential 
outliers for the TLFB (n = 2), NA subscale of the PANAS (n = 1), and BDI-II (n = 2) at baseline. 
Statistical significance of results did not change when outliers were excluded, so we included 
them in all analyses. 
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Primary and Secondary Hypotheses 
To test 30-day point prevalence abstinence and 50% smoking reduction at end of 
treatment and 3-month follow-up (Hypotheses 1-4), we employed intent-to-treat analysis with all 
58 randomized participants using the Chi-square statistic. For abstinence outcomes, participants 
were coded as smokers if they (1) reported smoking within the past 30 days; or (2) did not 
complete the end of treatment/3-month follow-up measures. For reduction outcomes, participants 
were coded as not reducing by 50% or more if they (1) did not reduce smoking by 50%; or (2) 
did not complete the end of treatment/3-month follow-up measures. In essence, the intent-to-treat 
analysis strategy identified participants with missing data as smokers. There were no significant 
differences between the intervention groups for any demographic or baseline variables. Thus, we 
did not statistically control for these variables in any of the models. 
Exploratory Hypotheses 
Feasibility estimates (Hypothesis 5) were determined by the ability to recruit and retain 
participants, treatment attendance, and treatment satisfaction, and were assessed by the following 
methods: Descriptive statistics summarized data related to participant recruitment and retention 
(Figure 1), including the total number of potential participants screened, excluded, and the 
number of participants that discontinued participation. In addition, descriptive statistics 
summarized treatment attendance and treatment satisfaction. 
For the remaining exploratory analyses, participants who completed at least 1 treatment 
session and for whom we had end of treatment/3-month follow-up data were included (n = 46 for 
end of treatment and n = 35 for 3-month follow-up). We excluded from end of treatment 
analyses 12 participants who did not complete any treatment sessions (n = 3), did not provide 
end of treatment data (n = 4), or did not complete sessions and did not provide end of treatment 
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data (n = 5). We excluded from 3-month follow-up analyses 23 participants who did not 
complete any treatment sessions (n = 3), did not provide 3-month follow-up data (n = 15), or did 
not complete sessions and did not provide 3-month follow-up data (n = 5). Repeated measures 
analysis of variance (ANOVA) compared differences in the number of cigarettes smoked per 
month, motivation, confidence, and affective and cognitive measures (Hypotheses 6-8) between 
CBT and CG participants from baseline to end of treatment and 3-month follow-up. A main 
effect for time and a treatment by time interaction were assessed. Lastly, to examine the 
relationship between baseline depressive symptoms and treatment attendance, linear regression 
analyses were employed across treatment condition (n = 53) with treatment attendance (sum of 
sessions attended, range = 0-6) as the criterion and baseline depression (BDI-II) as a main effect 
predictor. 
RESULTS 
Screened participants (n = 1,380) were mostly female (61.6%), Freshmen (71.2%), and 
had a mean age of 19.68 years (SD = 3.47) (Table 5). The mean number of days smoked in the 
past 30 days was 3.88 (SD = 8.90, Mdn = 0.00), and the mean CES-D score was 13.81 (SD = 
9.21). Scores on the Contemplation Ladder (M = 5.57, SD = 3.47) suggested that screened 
participants were thinking about quitting smoking at baseline, but had not made any definite 
plans to do so. Participants who consented to follow-up contact had significantly higher mean 
30-day smoking (t(616) = 6.32, p < .001) and depressive symptoms (CES-D) (t(410) = 3.28, p = 
.001) than participants who preferred not to be contacted. As expected, relative to ineligible 
participants (n = 1322), eligible participants (n = 58) had significantly higher 30-day smoking 
(t(62) = -19.81, p < .001), depression (t(1362) = -10.70, p < .001), and Contemplation Ladder 
scores (t(149) = -3.71, p < .001). In addition, eligible participants were significantly older than 
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non-eligible participants (t(60) = -2.34, p = .023) (Table 5). Among participants contacted via 
telephone for follow-up screening, those who agreed to participate (n = 58) were similar to those 
who refused or could not be reached (n = 24) (all ps > .05) on age, smoking rate (number of days 
smoked in past 30), depressive symptoms (CES-D), and motivation to quit (Contemplation 
Ladder). 
Table 6 presents demographic characteristics and baseline measure scores of the study 
sample that completed baseline questionnaires (n = 53) by intervention group (CBT and CG). No 
significant differences (all ps > .05) were observed between groups. At baseline, participants (n = 
53) were mostly Freshmen (67.9%) and had a mean age of 21.19 years (SD = 4.60) (Table 6). 
Over half (60.4%) reported past psychotherapy experience and almost 20% reported taking a 
psychotropic medication. Specifically, 11.3% reported taking antidepressants, 5.7% stimulants, 
3.8% mood stabilizers or anti-psychotics, and 3.8% benzodiazepines. The mean number of days 
smoked in the past 30 days was 24.77 (SD = 7.11) and 39.6% used other tobacco in addition to 
cigarettes. The mean BDI-II score was 13.71 (SD = 8.82), indicating mild depressive 
symptomatology. No significant differences existed between participants that completed baseline 
(n = 53) and those that did not complete baseline (n = 5) on screening variables such as 
demographic characteristics (age, gender, year in school), 30-day smoking, depression (CES-D 
and PHQ-9), and motivation (Contemplation Ladder) (all ps > .05). 
For the secondary and exploratory outcome analyses, only participants who completed at 
least one group session and end of treatment/3-month follow-up data were included (n = 46 at 
end of treatment and n = 35 at 3-month follow-up). No significant differences existed between 
these participants (n = 46 and n = 35) and those who did not complete group sessions and end of 
treatment/3-month follow-up (n = 12 and n = 23) on screening variables (all ps > .05). 
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Primary Outcomes 
Our primary outcome analyses (Hypotheses 1 & 2, n = 58) revealed that 30-day point 
prevalence abstinence did not differ significantly between CBT (6.9%; 2 of 29) and CG (3.4%; 1 
of 29) (χ
2
(1, N = 58) = .352, p = .553). However, the proportion of CBT participants (34.5%; 10 
of 29) that reduced their smoking by 50% was significantly greater than that of CG (10.3%; 3 of 
29) (χ
2
(1, N = 58) = 4.86, p = .028) (Figure 2). 
Secondary Outcomes 
With regard to abstinence and smoking reduction at 3 month follow-up (Hypothesis 3 & 
4), results revealed no significant differences between groups on 30-day point prevalence 
abstinence (10.3%; 3 of 29 in both groups, χ
2
(1, N = 58) = .000, p = 1.000). In addition, at 3-
month follow-up no significant differences emerged between groups on the proportion of 
participants that reduced their smoking by 50% (CBT: 24.1%; 7 of 29 and CG: 17.2%; 5 of 29) 
(χ
2
(1, N = 58) = .420, p = .747) (Figure 2). 
Exploratory Outcomes 
Results related to Hypothesis 5 show that CBT for college student smokers with elevated 
depressive symptoms was feasible, demonstrated by the ability to recruit and retain participants, 
treatment attendance, and treatment satisfaction. Out of 1380 potential participants screened, 58 
(4.2%) were randomized to participate in the study, which exceeds the estimated and proposed 
sample size of n = 50 (Figure 1). In addition, out of the participants that consented to be 
contacted and met screening criteria for smoking, depressive symptoms, motivation, and no 
MDD (n = 82), a moderate proportion (29.3%; 24 out of 82) refused to participate or could not 
be reached by study personnel (Figure 1). With regard to retention, 79.3% (n = 46, 23 in each 
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condition) of the 58 randomized participants completed at least one treatment session and end of 
treatment data. For treatment attendance, 75.9% (n = 44) of the 58 randomized participants 
completed at least 4 group sessions and numbers were similar across groups (CBT; n = 21, CG; n 
= 23). Participants reported that the incentives had a “moderate” influence in whether or not they 
continued to participate in the groups, and no significant group difference existed (p > .05). With 
regard to treatment satisfaction among the CBT participants, 60.8% (n = 14) found the group 
helpful for quitting smoking and 91.3% (n = 21) reported it was helpful for reducing smoking. 
Furthermore, all CBT participants said they would recommend the group to a friend for quitting 
or reducing smoking and 78.2% (n = 18) said they would come back to the group if they wanted 
to change their smoking in the future. Among the CG participants, 86.9% (n = 22) found the 
group helpful for increasing fruit and vegetable consumption. All CG participants said they 
would recommend the group to a friend for increasing fruit and vegetable consumption and 
86.9% (n = 20) said they would come back to the group if they wanted to increase their fruit and 
vegetable consumption in the future. Of note, 78.1% (n = 25) of participants across two cohorts 
of CBT and CG groups reported that they would prefer the group format to individual sessions. 
Table 7 presents exploratory outcome data for participants with complete data (n = 46 at 
end of treatment and n = 35 at 3-month follow-up). With regard to changes in number of 
cigarettes smoked in the past 30 days from baseline to end of treatment and 3-month follow-up 
(Hypothesis 6), repeated measures analysis of variance demonstrated a significant main effect for 
time (F(1, 44) = 7.60, p = .008, ηp
2
 = .147) such that the average number of cigarettes smoked in 
the past 30 days decreased from 235.22 (SD = 209.68) at baseline to 189.86 (SD = 227.32) at end 
of treatment. In addition, the treatment group by time interaction approached significance (F(1, 
44) = 2.95, p = .093, ηp
2
 = .063). At 3-month follow-up, repeated measures analysis of variance 
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demonstrated a significant main effect for time (F(1, 33) = 14.40, p = .001, ηp
2
 = .304), but no 
treatment group by time interaction (F(1, 33) = 2.41, p = .130, ηp
2
 = .068). 
For motivation to quit and reduce smoking (Hypothesis 7), a significant main effect for 
time emerged (Quit: F(1, 44) = 10.96, p = .002, ηp
2
 = .199; Reduce: F(1, 44) = 11.46, p = .002, 
ηp
2
 = .207) but not a significant treatment by time interaction at end of treatment (Quit: F(1, 44) 
= 2.23, p = .143, ηp
2
 = .048; Reduce: F(1, 44) = .02, p = .884, ηp
2
 = .000). No significant main 
(F(1, 44) = 1.83, p = .183, ηp
2
 = .040) or interaction effect (F(1, 44) = 0.12, p = .737, ηp
2
 = .003) 
emerged for confidence to quit smoking at end of treatment. However, a significant interaction 
effect was found for confidence to reduce smoking (F(1, 44) = 4.35, p = .043, ηp
2
 = .090) at end 
of treatment. CBT participants‟ average level of confidence to reduce smoking increased from 
baseline to end of treatment to a significantly greater degree than CG participants (Figure 3). At 
3-month follow-up, a significant main effect for time emerged for motivation to quit and reduce 
smoking (Quit: F(1, 33) = 9.05, p = .005, ηp
2
 = .215; Reduce: F(1, 33) = 4.57, p = .040, ηp
2
 = 
.122). Additionally, the treatment group by time interaction approached significance for 
motivation to quit (F(1,33) = 3.18, p = .084, ηp
2
 = .088), but not for motivation to reduce (F(1, 
33) = 0.73, p = .401, ηp
2
 = .022). For confidence to quit or reduce smoking at 3-month follow-up, 
no significant main (Quit: F(1, 33) = 0.48, p = .493, ηp
2
 = .014; Reduce: F(1, 33) = 0.66, p = 
.423, ηp
2
 = .020) or interaction effect (Quit: F(1, 33) = 0.31, p = .583, ηp
2
 = .009; Reduce: F(1, 
33) = 1.35, p = .254, ηp
2
 = .039) emerged. 
 With regard to affect (NA and PA), mood (BDI-II), and cognition (NAR expectancies 
and ERQ) outcomes (Hypothesis 8), no main (F(1, 44) = 0.55, p = .461, ηp
2
 = .012) or interaction 
effect (F(1, 44) = 0.28, p = .598, ηp
2
 = .006) was found for the NA subscale of the PANAS at end 
of treatment or 3-month follow-up (Main: F(1, 33) = 0.68, p = .417, ηp
2
 = .020; Interaction: F(1, 
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33) = 0.75, p = .394, ηp
2
 = .022). In addition, no main (F(1, 44) = 0.00, p = 1.00, ηp
2
 = .000) or 
interaction effect (F(1, 44) = 0.06, p = .815, ηp
2
 = .001) was found for the PA subscale of the 
PANAS at end of treatment or 3-month follow-up (Main: F(1, 33) = 0.07, p = .795, ηp
2
 = .002; 
Interaction: F(1, 33) = 2.59, p = .117, ηp
2
 = .073). For the BDI-II, a main effect for time 
approached significance (F(1, 44) = 3.23, p = .079, ηp
2
 = .068), but no significant treatment by 
time interaction emerged (F(1, 44) = 1.86, p = .180, ηp
2
 = .041) at end of treatment. At 3-month 
follow-up, no main (F(1, 33) = 0.59, p = .448, ηp
2
 = .018) or interaction effect (F(1, 33) = 0.19, p 
= .670, ηp
2
 = .006) was found for the BDI-II. For the Negative Affect Reduction (NAR) subscale 
of the SCQ, we detected a significant main effect for time (F(1, 44) = 7.03, p = .011, ηp
2
 = .138), 
but no interaction effect (F(1, 44) = 0.52, p = .474, ηp
2
 = .012) at end of treatment. In addition, at 
3-month follow-up with the NAR subscale we found a significant main effect for time (F(1, 33) 
= 12.14, p = .001, ηp
2
 = .269), but no interaction effect (F(1, 33) = 0.17, p = .684, ηp
2
 = .005). No 
main (F(1, 44) = 0.50, p = .484, ηp
2
 = .011) or interaction effect (F(1, 44) = 0.09, p = .769, ηp
2
 = 
.002) was found for the Reappraisal subscale of the ERQ at end of treatment or 3-month follow-
up (Main: F(1, 33) = 1.95, p = .172, ηp
2
 = .056; Interaction: F(1, 33) = 0.41, p = .528, ηp
2
 = .012). 
 For the relationship between baseline depressive symptoms and treatment attendance, 
linear regression analyses indicated that baseline depressive symptoms were not a significant 
predictor of treatment attendance (B = .02, SE B = .03, β = 0.07, p = .620). 
DISCUSSION 
College student smoking rates are high and there is evidence that smoking initiation and 
progression during the college years may influence adult smoking patterns. Furthermore, the 
presence of depressive symptoms among college smokers is concerning, especially because it 
may impede cessation efforts. Despite promising evidence for mood management interventions 
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among smokers with clinically elevated depressive symptoms, no interventions of this kind have 
been developed and tested for depressed college smokers. Thus, this study tested a multi-
component psychotherapeutic smoking reduction/cessation intervention designed for college 
student smokers with elevated depressive symptoms. 
The primary outcomes focused on smoking reduction and cessation. We found a 
significantly greater proportion of CBT participants reduced smoking by at least 50% compared 
to CG participants at end of treatment. This finding is remarkable given the small-scale nature of 
our study. Smoking reduction is important given that many college students are not interested in 
quitting immediately. For example, at baseline our sample had only a moderate interest in 
quitting or reducing tobacco use. Researchers have found that spontaneous reduction is rare and 
that smokers who reduce can maintain these reductions (Hughes & Carpenter, 2005). Therefore, 
smoking reduction can be viewed as a significant outcome for the CBT group because it is 
unlikely to happen on its own. In addition, there is some evidence that smoke exposure decreases 
for those who reduce (Hughes & Carpenter, 2005) suggesting direct health implications for 
reduction. Furthermore, given that smoking reduction increases the likelihood of future cessation 
(Hughes & Carpenter, 2006), reductions made by CBT participants are an important step on the 
path toward quitting. It is very possible that the smoking reductions that took place in the CBT 
group may build self-efficacy for future quit attempts. 
Indeed, we found a significant interaction effect such that CBT participants‟ confidence 
to reduce smoking increased from baseline to end of treatment whereas it decreased for CG 
participants. Confidence to change smoking behavior is similar to „quitting self-efficacy‟ which 
is related to initiation of quit attempts (Baldwin et al., 2006), intention to continue smoking 
(Landrum Sterling et al., 2007), and stage of change (Apodaca, Abrantes, Strong, Ramsey, & 
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Brown, 2007; Hoving, Mudde, & de Vries, 2006). It is likely that making a behavior change 
increases confidence and vice versa, and CBT participants may gain momentum toward 
cessation if they continue to experience the combined effects of reduction and increases in 
confidence. For instance, if confidence to reduce increases, then it may lead to confidence to quit 
over time. Building self-efficacy is important for those making a quit attempt because low self-
efficacy may predict relapse after cessation (Baer, Holt, & Lichtenstein, 1986; McIntyre, 
Lichtenstein, & Mermelstein, 1983; Shiffman et al., 2000). Moreover, increasing confidence may 
be especially vital for depressed smokers given that currently depressed smokers have been 
found to have lower smoking cessation self-efficacy (Haukkala, Uutela, Vartiainen, McAlister, 
& Knekt, 2000; John, Meyer, Rumpf, & Hapke, 2004b). Although the interaction effect was not 
significant at 3-month follow-up, CBT participants‟ confidence to reduce smoking was 
maintained (Table 7). In addition, the interaction effect for motivation to quit at 3-month follow-
up approached significance, suggesting that CBT participants‟ motivation increased from 
baseline to 3-month follow-up to a greater degree than CG participants. This promising finding 
may be related to the synergistic effects that behavioral change and increased confidence can 
have on motivation to quit. Increasing motivation to quit is an important step toward quitting. 
Overall, few participants quit smoking across both groups. Although this finding differs 
substantially from outcomes of mood management interventions among depressed adult 
smokers, our study design differed from adult studies because we recruited occasional smokers 
not ready to quit immediately. Qualitative reflections of CBT group leaders suggested that few 
participants seemed interested in quitting, and participants‟ interest in reducing may have 
resulted from a compromise related to their ambivalence toward quitting (e.g., “I want to quit, 
but there are enough reasons to sustain my use. Reducing is appealing because it is a step toward 
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quitting, yet I am still able to smoke”). In addition, CBT participants commented that they were 
not ready to make a commitment to quitting now and talked about quitting as something they 
“just had to be ready for.” Based on anecdotal evidence provided by CBT group leaders, 
participants appeared aware of the current side effects of smoking, like difficulty breathing, 
coughing up blood, and the smell of tobacco smoke on their hands, breath, and clothes. Despite 
this awareness, they felt the immediate benefits of smoking (e.g., relieving stress, smoking being 
enjoyable, and smoking being associated with drinking and socializing) outweighed the negative 
physical effects. Participants reported awareness of the long-term risks of cigarette smoking 
(e.g., cancer), but appeared to consider the short-term benefits as more appealing than potential 
long-term consequences. Taken together, these observations based on clinical data from CBT 
participants suggest that smoking reduction might be a more feasible short-term outcome than 
cessation for smoking interventions among college smokers. 
The secondary outcomes evaluated abstinence and reduction at 3-month follow-up. 
Results showed that neither smoking abstinence nor smoking reduction rates differed 
significantly between groups. Notably, abstinence and reduction rates increased from end of 
treatment to 3-month follow-up in both groups (with the exception of a small decrease in 50% 
reduction for the CBT group). These findings may indicate that progress in quitting and reducing 
smoking remained fairly consistent for the CBT group whereas it increased for CG participants 
over time. Indeed, number of cigarettes smoked in the past month did not increase, but remained 
largely the same from end of treatment to 3-month follow-up in the CBT group. Patten et al. 
(1998) found similar results such that abstinence rates in the CBT group were significantly 
higher than standard behavioral counseling at end of treatment and 12-month follow-up, but not 
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at 3-month follow-up. Six-month follow-up data for this study will be forthcoming and may 
show a similar trend. 
The exploratory results related to overall reduction in number of cigarettes smoked in the 
past month revealed a trend toward greater reduction in the CBT group versus the CG group at 
end of treatment. With more statistical power, this finding would likely be significant given the 
medium effect size of the interaction term (ηp
2
 = .063, where .02, .06, and .14 represent small, 
medium, and large effect sizes (Cohen, 1988)). This finding parallels the significant finding for 
50% reduction at end of treatment and has similar implications for increased health, future 
quitting, and enhanced confidence to quit. Although group differences in reduction in number of 
cigarettes smoked in the past month were not significant at 3-month follow-up, it is important to 
note that reductions were maintained by the CBT group from end of treatment to 3-month 
follow-up. Maintenance of reduction by the CBT group suggests that the intervention might have 
durable effects. 
Findings related to recruitment, retention, treatment adherence, and satisfaction support 
the feasibility of this intervention for depressed college student smokers. We recruited more 
participants than our projected sample size of 50, and a substantial number (70.7%) of those 
contacted to participate agreed. Likewise, we had low attrition and few missed sessions across 
both groups, which is especially notable given that participants were not necessarily seeking any 
type of treatment. It is important to mention that we were diligent about following up when 
participants missed sessions and about scheduling make-up sessions. Participant incentives were 
rated as only “moderately” important for participants‟ continued engagement in the study. 
Consistent with this, CBT group leaders observed CBT participants‟ comments that they had 
made a commitment to attending sessions and planned to honor that commitment, and that they 
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enjoyed meeting with a group of college students to discuss smoking. These observations 
suggested that group smoking interventions may be particularly useful for enhancing 
participation and lowering attrition. 
Given that this is a new treatment in a previously understudied population, our findings 
for high treatment satisfaction in the CBT group are noteworthy. Over half (61%) of CBT 
participants found the group helpful for quitting smoking and almost all (91%) found it helpful 
for reducing smoking. Moreover, the likelihood that a similar intervention would be used in the 
future is high given that all participants said they would recommend the group to a friend. Nearly 
80% of CBT participants reported they would return to the group in the future if they wanted to 
change their smoking. Thus, the intervention was useful for reducing smoking in a sample with 
low motivation to quit, and it was also well received and viewed positively by a group of non-
treatment seeking college smokers. Treatment satisfaction was similarly high in the nutrition 
group. In conjunction with the lack of between group differences in retention and attendance, 
these satisfaction data support the use of this nutrition-focused group as an adequate control 
group. 
With regard to negative affect and depressive symptoms, our findings showed trends in 
the expected direction at end of treatment such that negative affect and depressed mood 
decreased in CBT participants and remained largely the same in the CG group (Table 7). 
Statistically significant differences between groups would likely emerge with a larger sample 
size and might provide insight into the mechanism of action for the 50% reduction finding. 
Interestingly, both affect (NA and PA) and mood worsened slightly across groups from end of 
treatment to 3-month follow-up. It is difficult to know the source or stability of these changes, 
but 6-month follow-up data might provide more information. For example, if affect and mood 
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improve for both groups at 6-month follow-up it may mean that these variables are subject to 
slight fluctuations in a college sample. Despite the worsening of affect and mood at 3-month 
follow-up, cognitive reappraisal strategies increased slightly from end of treatment to 3-month 
follow-up. Again, this finding warrants follow-up because we would expect affect and mood and 
cognitive strategies to improve (or worsen) together over time. 
Results related to the exploratory hypotheses also revealed significant main effects for 
time such that overall number of cigarettes smoked per month and negative affect regulation 
expectancies decreased, whereas motivation to quit and reduce increased from baseline to end of 
treatment and 3-month follow-up across groups. These main effects for time indicate that there 
might be some benefit to participating in a health-focused group. However, it is important to 
point out that an increase in confidence and significant reduction (≥ 50%) occurred at end of 
treatment with the extra attention paid to smoking behavior in the CBT group. 
Lastly, we examined the relationship between baseline depressive symptoms and 
treatment attendance because there is some evidence to suggest that smokers experiencing more 
depressive symptomatology are more likely to attend CBT treatment sessions compared to 
smokers with lower depressive symptoms (Patten et al., 2002). However, results revealed no 
significant relationship between baseline BDI-II scores and attendance. It is possible that we did 
not have enough variability in depression scores given that we selected for clinically elevated 
depressive symptomatology. 
There are a few limitations to note. First, this was a small-scale study intended to 
evaluate the promise of this novel intervention before conducting a larger scale study. As such, 
our sample size is small, which might represent a limitation. On the other hand, the small sample 
places our significant results in context and suggests that some of the observed statistical trends 
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would likely achieve significance with a larger sample size. Second, our primary outcomes were 
examined at end of treatment and 3-month follow-up. Six-month follow-up data are being 
collected and planned analyses will confirm whether reductions were maintained over a longer 
length of time. Third, related to sample demographics, our study was conducted at a single site, 
and the majority of the participants were white and early in their college careers. Future studies 
should examine a more diverse group of participants and generalization of the present results 
should be done with caution. In addition, future studies could investigate which components 
(behavioral, mood management, or motivational) of the combined intervention are responsible 
for smoking reduction and increases in confidence. Lastly, it is not possible to biochemically 
confirm smoking cessation over a 30-day period. It should be noted that our results are based on 
self-report and that we used saliva samples to help increase the accuracy of self-reporting. 
Concluding Comments and Reflections 
To our knowledge, our study is the first to evaluate a multi-component treatment among 
college smokers with elevated depressive symptoms. Given this novelty, we encountered a few 
surprises and challenges along the way. With regard to surprises, CBT group leaders remarked 
how engaged participants were in group discussion. Some CBT participants commented that they 
do not talk about smoking with their friends and that they liked having the opportunity to talk 
with other college smokers about their experiences. Participants stated that they felt validated to 
hear that other people experience similar side effects, like coughing upon waking and difficulty 
breathing. Group leaders noted that participants had many shared experiences, like difficulty 
quitting when all their friends smoke and perceptions of isolation related to being the “odd man 
out” if everyone else at a party was smoking and they were not. In addition, group leaders 
commented that CBT participants enjoyed discussing how they felt irritated and wanted to 
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smoke more when strangers reacted negatively toward their smoking (e.g., plugging their nose as 
they walk by or saying, “That stuff will kill you”). Overall, there appeared to be the sense that if 
the participants were going to quit it would be on their own terms and in their own way. This 
quality of individuation and independence should be noted when working with college student 
smokers. Another surprise was that many participants did not seem to realize that they were in a 
group of moderately depressed individuals. CBT group leaders commented that when 
participants talked about mood regulation, they talked about stress, but not sadness or depression. 
Although it is possible that being in a group with other students may have made it more difficult 
for participants to talk openly about depressed mood; it is also possible that the link between 
depression and smoking was less clear to participants than group leaders intended it to be. In the 
future, it may be effective to talk about low mood directly and how it is associated with 
ineffective coping styles, such as smoking and how smoking may perpetuate low mood. Talking 
about how smoking as a coping strategy influences mood may be an avenue to tap into 
participant values because many people do not want to feel sad or depressed. Thus, depression 
may provide an opportunity to link smoking to values in terms of motivational enhancement. 
However, care should be taken when addressing mood and coping more directly in a group 
setting because people may feel sensitive about experiencing low mood. It might be helpful to 
talk about low mood as something that everyone experiences and how it affects coping, and then 
go from there. In other words, group leaders would not single people out, but would take care to 
talk about it in a more general sense. 
With regard to challenges encountered, there was some difficulty in combining skills 
training (cognitive or behavioral) and motivational enhancement. For example, group leaders 
commented that it was challenging to teach coping skills to a group of participants that were not 
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motivated to use them. Over three cohorts of groups, CBT group leaders modified the treatment 
manual by incorporating more motivation in the beginning sessions and more skills training in 
the end. Most CBT smoking interventions have been designed for smokers engaged in a quit 
attempt where CBT is used to help smokers cope with that quit attempt. It is possible that mood 
management approaches are less appropriate for smokers not ready to quit immediately because 
they are not faced with the total absence of an apparently helpful but ultimately harmful mood 
regulating strategy (i.e., smoking). Therefore, it may be more effective for the CBT component 
to come later in the change process when smokers are ready to make a quit attempt. Also related 
to the discontinuity between skills training and motivation, most participants did not do assigned 
homework aside from self-monitoring of smoking. To compensate for this, group leaders had 
participants give examples of self-management of smoking, challenges of thought distortions, 
etc. in session. Additionally, group dynamics affected the motivational enhancement component. 
For example, in one cohort there was an outspoken “pro-smoking” group member, which seemed 
to influence the group dynamic in a direction away from change. However, for the other two 
cohorts, group leaders noted that more participants were at the upper end of the motivation scale 
which seemed to promote change talk. It may be the case that group motivational enhancement is 
more effective when the group overall leans in the motivated direction and that one strong 
dissenter can impact group progress. Rolling with resistance is a core principle of motivational 
interviewing and therapists should continue to work with dissenters in this manner. However, in 
groups therapist control over resistance may be reduced because non-motivational interviewing 
strategies may arise among group members (e.g., other members may not roll with resistance or 
be accepting of others‟ point of view). 
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There were also a few challenges related to logistic issues. For example, our initial plan 
for monitoring therapist adherence was to use tapes from group sessions to rate adherence to the 
manuals. However, because this was a pilot study, we found that the outline of group topics 
needed to be modified by cohort to increase intervention effectiveness. In addition, tapes were 
incomplete and so we substituted case notes for a less-detailed analysis of therapist adherence. 
CBT group participants also reported that two hours was too long to sit in the group and that they 
preferred one and a half hour groups. Lastly, group CBT leaders recommended that the six 
sessions occur weekly instead of including a month break because of lost momentum over the 
break and participant fatigue at the end of the semester when the final group session took place. 
Despite the limitations and challenges encountered, this study shows promising evidence 
for the utility of this multi-component treatment for smoking reduction among college smokers 
with elevated depressive symptoms. CBT participants reported that the groups made them more 
aware of their smoking and made their behavior less automatic, which helped them change their 
use. Depressed college smokers are an understudied population and positive behavior change in 
these smokers is significant given that they were not treatment seeking and were not motivated to 
quit immediately. The large smoking reductions found in our CBT group also have high clinical 
significance because reducing smoking may lower morbidity and lead to future smoking 
cessation. 
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Table 1 
Eligibility 
 
 
 
 
 
 
 
 
 
 
Inclusion criteria  Exclusion criteria 
 Age 18 years or older 
 Smoked on 6 or more days out of the past 
30 days 
 CES-D Sum ≥ 16 
 Contemplation Ladder score ≥ 3 
 Enrolled with undergraduate standing at 
The University of Montana 
 Willing to participate in all study 
components 
 Provided informed consent 
  No current Major Depressive Disorder 
(MDD) 
 No current suicidal intent or plan 
 No participation in another structured 
cessation program in the past 30 days 
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Table 2 
Study Overview and Incentives 
Note. *Date range from first cohort. 
 
Session Week Activity Date range* Incentive type 
Screening -1 Screen, Randomize September 2 credits 
Session 1 
(Baseline) 
0 
CBT or CG Sessions 
Baseline Measures 
October 4 credits 
Session 2 1 CBT or CG Sessions October 2 credits, $5 
Session 3 2 CBT or CG Sessions October 
$5, Non-monetary 
incentives 
Session 4 3 CBT or CG Sessions October 
$5, Non-monetary 
incentives 
Session 5 
 
4 CBT or CG Sessions October 
$5, Non-monetary 
incentives 
Session 6 
(End of treatment) 
8 
CBT or CG Sessions 
End of Treatment Measures 
November $20 
3-month follow-up 12 
3-month Follow-up 
Measures 
February $10 
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Table 3 
Topics Covered in Group Sessions for Treatment (CBT) and Control (CG) Conditions 
Note. The session in which topics were covered varied slightly by cohort. 
 
Session CBT CG 
Session 1 Introduce social learning approach, 
assess motivation, and explain self-
monitoring of smoking and triggers. 
Assess motivation, discuss 5 a day, 
discuss health benefits, sample 
fruit/vegetable (f/v), plan and set goals. 
Session 2 
 
Introduce behavioral chain, assess 
motivation, introduce self-management 
approach, and introduce thought 
distortions. 
Assess motivation, sample f/v, discuss 
portion size, discuss colorful f/v, plan 
and set goals. 
Session 3 
 
Assess motivation, review self-
management approach, review 
behavioral chain, and introduce 
disputing thought distortions. 
Assess motivation, sample f/v, discuss 
organic produce, discuss how to clean 
f/v, discuss fresh, canned, frozen, and 
dried f/v, discuss where to buy f/v, plan 
and set goals. 
Session 4 
 
Assess motivation, review self-
management approach, review methods 
for disputing thought distortions, and 
set and plan for quit date. 
Assess motivation, discuss label 
reading, field trip to local grocery store, 
plan and set goals. 
Session 5 Assess motivation, review self-
management approach, review 
disputing thought distortions, and 
introduce relapse prevention. 
Assess motivation, discuss eating f/v on 
campus, sample f/v, discuss easy 
recipes, plan and set goals. 
Session 6 Review progress, assess motivation, 
review self-management and disputing 
thought distortions, and plan for the 
future 
Review progress, assess motivation, 
review, discuss establishing a routine, 
and plan for the future 
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Table 4 
Percent of Sessions Topics were Covered 
 Intervention Topics 
Cohort, Intervention Group CBT  Behavioral 
Counseling 
Motivation F/V 
Education 
Cohort 1, CBT 91.7 100 58.6 0 
Cohort 2, CBT 75.0 100 75.0 0 
Cohort 3, CBT 66.7 91.7 91.7 0 
Cohort 1, CG 0 0 41.7 100 
Cohort 2, CG 0 0 66.7 91.7 
Cohort 3, CG 0 0 91.7 100 
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Table 5 
Screening Sample Characteristics 
 
 
 
 
 
 
 
 
 
Note. * p<.05, Eligible = met inclusion/exclusion criteria, 30-day Smoking = number of days 
smoked in the past 30 days, CES-D = Center for Epidemiological Studies-Depression Scale. 
a 
Total sample (n=1380) includes participants with missing data on 30-day Smoking (n=1), CES-D 
Score (n=16), and Contemplation Ladder (n=75).
  Eligible  
 Total
a
 Yes No p-value 
Characteristics of Sample n (%) 1380 58 (4.2) 1322 (95.8)  
Age: M (SD) 19.68 (3.47) 21.00 (4.45) 19.62 (3.41)   .023* 
30-day Smoking: M (SD) 3.88 (8.90) 23.72 (7.79) 3.01 (7.88) <.001* 
CES-D Score: M (SD) 13.81 (9.21) 25.13 (8.20) 13.31 (8.93) <.001* 
Contemplation Ladder: M (SD) 5.57 (3.47) 6.66 (2.11) 5.32 (3.67) <.001* 
Gender: n (%)      .114 
Female 850 (61.6) 30 (51.7) 820 (62.0)    
Male 530 (38.4) 28 (48.3) 502 (38.0)  
Year in School: n (%)      .683 
Freshman 982 (71.2) 41 (70.7) 941 (71.2)  
Sophomore 246 (17.8) 13 (22.4) 233 (17.6)  
Junior 106 (7.7) 2 (3.4) 104 (7.9)  
Senior 29 (2.1) 1 (1.7) 28 (2.1)  
Other 17 (12.0) 1 (1.7) 16 (1.2)  
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Table 6 
Demographic Characteristics and Baseline Measure Scores by Intervention Group 
Note. 
a 
Total sample (n = 53) includes one participant who refused to provide ethnicity data and 
excludes five participants (CBT n = 3, CG n = 2) who did not complete baseline data. 
b 
Fisher‟s 
exact test used. 30-day Smoking = Number of days smoked in the past 30 days; PANAS = 
Positive and Negative Affect Schedule; BDI-II Score Beck Depression Inventory-II; SCQ = 
 
 
 
 
Intervention group 
 
Total
 a
 
(n = 53) 
CBT 
(n = 26) 
CG 
(n = 27) 
p-value 
Demographic Characteristics, n (%)     
Age, M (SD) 21.19 (4.60) 20.58 (4.34) 21.78 (4.85) .347 
Gender    .217 
Female 27 (50.9) 11 (42.3) 16 (59.3)  
Male 26 (49.1) 15 (57.7) 11 (40.7)  
Year in School    .361 
Freshman 36 (67.9) 20 (76.9) 16 (59.3)  
Sophomore 13 (24.5) 4 (15.4) 9 (33.3)  
Junior 2 (3.8) 1 (3.8) 1 (3.7)  
Senior 1 (1.9) 0 1 (3.7)  
Other 1 (1.9) 1 (3.8) 0  
Ethnicity    .703 
White 44 (84.6) 23 (88.5) 21 (80.8)  
Other 8 (15.4) 3 (11.5) 5 (19.2)  
Psychotherapy Experience, Yes     
Current 4 (7.5) 3 (11.5) 1 (3.7) .280 
Past 32 (60.4) 16 (61.5) 16 (59.3) .865 
Psychotropic Medication, Yes 10 (18.9) 6 (23.1) 4 (14.8) .501
 b
 
Other 30-day tobacco use, Yes 21 (39.6) 10 (38.5) 11 (40.7) .865 
Baseline Measures, M (SD)     
30-day smoking 24.77 (7.11) 25.50 (6.50) 24.07 (7.71) .471 
PANAS Negative Affect score 16.19 (5.30) 17.42 (5.99) 15.00 (4.32) .096 
Motivation to Quit 6.00 (2.70) 5.81 (2.80) 6.19 (2.65) .616 
Motivation to Reduce 7.00 (2.87) 7.27 (2.69) 6.74 (3.06) .508 
Confidence to Quit 6.89 (2.66) 6.96 (2.55) 6.81 (2.80) .843 
Confidence to Reduce 7.92 (2.34) 7.92 (2.33) 7.93 (2.39) .997 
PANAS Positive Affect score 25.43 (7.74) 24.31 (7.17) 26.52 (8.27) .303 
BDI-II score 13.71 (8.82) 15.49 (9.84) 12.00 (7.50) .151 
SCQ Negative Affect Reduction score 7.69 (1.95) 7.76 (1.94) 7.62 (1.99) .798 
ERQ Reappraisal score 4.37 (1.16) 4.38 (1.19) 4.36 (1.15) .965 
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Smoking Consequences Questionnaire; ERQ = Emotion Regulation Questionnaire.
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Table 7 
Means and Standard Deviations for Exploratory Outcomes by Intervention Group 
 
  Intervention Group 
Exploratory Outcome Measures Total
 a
 
(n = 46, EOT) 
(n = 35, 3-month) 
CBT 
(n = 23, EOT) 
(n = 20, 3-month) 
CG 
(n = 23, EOT) 
(n = 15, 3-month) 
Smoking    
Cigs 30-days    
Baseline 235.22 (209.68) 239.78 (170.01) 230.65 (246.95) 
EOT 189.87 (227.32)
 b
 166.17 (155.10) 213.57 (283.68) 
3-month  178.97 (202.40)
 b
 166.70 (166.54) 195.33 (247.67) 
Motivation    
Motivation to Quit    
Baseline 5.74 (2.70)
 
 5.83 (2.96) 5.65 (2.48) 
EOT 6.85 (2.49)
 b
 7.43 (2.37) 6.26 (2.53) 
3-month  7.37 (2.26)
 b
 8.05 (1.50) 6.47 (2.80) 
Motivation to Reduce    
Baseline 6.65 (2.89)
 
 7.13 (2.80) 6.17 (2.96) 
EOT 8.15 (2.78)
 b
 8.70 (2.31) 7.61 (3.15) 
3-month  8.20 (2.68)
 b
 8.60 (2.56) 7.67 (2.82) 
Confidence to Quit    
Baseline 6.87 (2.71) 6.91 (2.64) 6.83 (2.84) 
EOT 7.39 (2.83) 7.30 (2.69) 7.48 (3.03) 
3-month  7.40 (2.84) 7.45 (2.72) 7.33 (3.09) 
Confidence to Reduce    
Baseline 7.87 (2.45) 7.78 (2.43) 7.96 (2.51)
 
 
EOT 8.33 (2.85) 9.09 (2.02)
 c
 7.57 (3.36)
 c
 
3-month  8.46 (1.92) 8.60 (1.64) 8.27 (2.28) 
Affect, Mood and Cognition    
PANAS-Negative Affect    
Baseline 16.74 (5.43) 18.17 (5.95) 15.30 (4.53) 
EOT 15.98 (6.03) 16.87 (7.12) 15.09 (4.68) 
3-month  17.60 (6.80) 17.65 (7.43) 17.53 (6.12) 
PANAS-Positive Affect    
Baseline 25.26 (7.32) 24.83 (7.38) 25.70 (7.39) 
EOT 25.26 (7.20) 24.61 (7.81) 25.91 (6.64) 
3-month  24.17 (7.45) 23.60 (8.29) 24.93 (6.36) 
BDI-II    
Baseline 13.95 (9.12) 15.95 (10.37) 11.96 (7.38) 
EOT 12.05 (8.21) 12.61 (8.74) 11.50 (7.80) 
3-month  12.43 (10.38) 13.05 (11.42) 11.60 (9.14) 
SCQ-Negative Affect Reduction    
Baseline 7.67 (2.07)
 
 7.84 (2.03) 7.50 (2.13) 
EOT 7.01 (2.60)
 b
 7.36 (2.40) 6.66 (2.79) 
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3-month  6.91 (2.39)
 b
 6.91 (2.35) 6.92 (2.53) 
ERQ-Reappraisal    
Baseline 4.39 (1.22) 4.35 (1.25) 4.43 (1.21) 
EOT 4.28 (1.28) 4.19 (1.23) 4.36 (1.35) 
3-month  4.62 (0.98) 4.68 (0.64) 4.54 (1.33) 
Note. 
a 
= Total sample at end of treatment (n = 46) excludes 12 participants who did not 
complete any treatment sessions (n = 3), did not provide end of treatment data (n = 4), or did not 
do both (n = 5). Total sample at 3-month follow-up (n = 35) excludes 23 participants who did not 
complete any treatment sessions (n = 3), did not provide 3-month follow-up data (n = 15), or did 
not do both (n = 5). 
b 
= Significant main effect for time (p < .05); 
c 
= Significant treatment by 
time interaction effect (p < .05); EOT = End of Treatment; 3-month = 3-month Follow-up; Cigs 
30-days = Number of cigarettes smoked in the past 30 days; PANAS = Positive and Negative 
Affect Schedule; BDI-II = Beck Depression Inventory-II; SCQ = Smoking Consequences 
Questionnaire; ERQ = Emotion Regulation Questionnaire. 
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Assessed for eligibility at screening 
(n = 1380) 
Randomized (n = 58) 
Excluded (n = 1322), Reasons:* 
Did not consent to be contacted (n = 253) 
Smoking criterion not met (n = 1163) 
Depressive symptoms criterion not met (n = 892) 
Motivation criterion not met (n = 1145) 
Current Major Depression (n = 4) 
Refused to participate (n = 6) 
Could not be reached (n = 18) 
*Reasons are not mutually exclusive 
Allocated to Smoking Group (CBT) (n = 29) 
Completed Baseline questionnaires: n = 26 
Completed 0 Sessions: n = 4
a
 
Completed 1 Session: n = 1 
Completed 2 Sessions: n = 2 
Completed 3 Sessions: n = 1 
Completed 4 Sessions: n = 0 
Completed 5 Sessions: n = 2 
Completed 6 Sessions: n = 19 
a
Reasons: Refused to participate, could not be 
reached, or had time constraints 
Allocated to Nutrition Group (CG) (n = 29) 
Completed Baseline questionnaires: n = 27 
Completed 0 Sessions: n = 4
b
 
Completed 1 Session: n = 1 
Completed 2 Sessions: n = 1 
Completed 3 Sessions: n = 0 
Completed 4 Sessions: n = 2 
Completed 5 Sessions: n = 1 
Completed 6 Sessions: n = 20 
b
Reasons: Refused to participate or had time 
constraints 
 
Withdrew consent (n = 0) 
Lost to end of treatment (could not be 
reached) (n = 5) 
Lost to 3-month follow-up (could not be 
reached) (n = 8) 
Withdrew consent (n = 2) 
Lost to end of treatment (could not be reached) 
(n = 2) 
Lost to 3-month follow-up (could not be 
reached) (n = 10) 
Analyzed for primary outcomes using intent 
to treat analyses (n = 29) 
Analyzed for secondary & exploratory 
outcome analyses (n = 23 at end of treatment 
and n = 20 at 3-month follow-up) 
 
Analyzed for primary outcomes using intent to 
treat analyses (n = 29) 
Analyzed for secondary & exploratory outcome 
analyses (n = 23 at end of treatment and n = 15 at 
3-month follow-up) 
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